Article
Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jul 2012
Romero A, Martín M, Oliva B, de la Torre J, Furio V, de la Hoya M, García-Sáenz J A, Moreno A, Román J M, Diaz-Rubio E, Caldés T
Abstract excerpt
BACKGROUND: Identification of predicting factors for anthracyclines-based chemotherapy remains a clinical challenge. Glutathione S-transferase (GSTs) enzymes detoxify chemotherapy drugs and their metabolites. Several polymorphisms in GST genes result in reduced or no activity of the enzymes. Specifically, GSTM1 and GSTT1 genes are polymorphically deleted, the polymorphism GSTP1 c.313A>G (rs1695) determines the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
